Utilize este identificador para referenciar este registo: https://hdl.handle.net/1822/37929

Registo completo
Campo DCValorIdioma
dc.contributor.authorFaria, D. R.por
dc.contributor.authorSakita, K. M.por
dc.contributor.authorTobaldini, F. K.por
dc.contributor.authorAkimoto-Gunther, L.por
dc.contributor.authorNegri, M.por
dc.contributor.authorKioshima, E. S.por
dc.contributor.authorSvidzinski, T. I. E.por
dc.contributor.authorBonfim-Mendonça, P. S.por
dc.date.accessioned2015-11-03T14:39:02Z-
dc.date.available2015-11-03T14:39:02Z-
dc.date.issued2015-
dc.identifier.citationFaria, D. R.; Sakita, K. M.; Tobaldini-Valerio, Flávia; Akimoto-Gunther, L.; Grassi, M.; Kioshima, E.; Svidzinski, T. I. E.; Bonfim-Mendonça, P. S., Assessment of in vitro biofilm formation and antifungal susceptibility of Candida albicans isolates from vulvovaginal candidiasis. 7th Trends in Medical Mycology. Vol. 58(Suppl. 4), Lisbon, Portugal, 9-12 Oct, 83-83, 2015.-
dc.identifier.issn0933-7407por
dc.identifier.urihttps://hdl.handle.net/1822/37929-
dc.description.abstractObjectives Vulvovaginal candidiasis (VVC) is an inflammation of the genital mucosa, which mainly affects the vulva and vagina. Candida spp. are considered commensal fungus, however, when there is imbalance in the microbiota or the host immune system is compromised, these can become pathogenic. C. albicans is responsible for most cases of VVC and is able of expressing mechanisms which allow the colonization or infection in the host. These factors related yeasts, including the growth of strains resistant to antifungal agents and virulence attributes (such as biofilm formation) are important in the development of VVC. In this sense, the objective of this study was to evaluate the in vitro biofilm formation and susceptibility to antifungal of C. albicans isolates from patients with vulvovaginal candidiasis. Methods For the study were analyzed 30 clinical isolates of Candida albicans. The clinical isolates were separated in groups of 10 samples of the according to symptoms presented by the patients: asymptomatic (AS), vulvovaginal candidiasis (VVC) and recurrent vulvo- vaginal candidiasis (RVVC). For all isolates were analyzed biofilm formation and minimal inhibitory concentration (MIC) for fluconazole and nystatin. The MIC was performed according to M27-A3 protocol of the Clinical Laboratory Standards Institute. Biofilm forming ability was assessed through quantification of total biomass by crystal violet (CV) staining, performed on 96-well microplates containing a cellular suspension of 1 9 107 cells ml1 and incubated for 24 h at 37°C. Results Antifungal susceptibility testing is showed in table 1. The isolates were tested to the two antifungals. The MIC raging from 0.125 to 2 lg ml1 for fluconazole and 1 to 4 lg ml1 to nystatin. The figure 1 show the quantification of the total biomass. It was evident that all the C. albicans isolates were able to form biofilm, although differences occurred depending on the isolated and consequently the group. Importantly it was noted that, in general, VVC and RVVC groups had similar capacity biofilm formation. On the other hand, these groups had less total biomass (average Abs = 1,091 ` 0.88) compared with AS group (average Abs = 1,521 ` 1.32). Conclusion Although all the samples analyzed are sensitive to anti- fungals tested research of resistant strains is relevant, since recurrences are related to cases of VVC. Nystatin and fluconazole were effective in small concentrations for the isolates analysed. All samples were able to form biofilm and the average of the group of asymptomatic patients greater than the others. Thus, the capacity to form- ing biofilm is an important virulence factor in the persistence of microorganisms in infectious processes and represent an increase in resistance to antifungal and host defense.por
dc.language.isoengpor
dc.publisherWiley-Blackwellpor
dc.rightsopenAccesspor
dc.titleAssessment of in vitro biofilm formation and antifungal susceptibility of Candida albicans isolates from vulvovaginal candidiasispor
dc.typeconferenceAbstract-
dc.peerreviewedyespor
dc.relation.publisherversionhttp://www.timm2015.org/por
dc.commentsCEB23442por
sdum.publicationstatuspublishedpor
oaire.citationConferenceDate09 - 12 Oct. 2015por
sdum.event.typeconferencepor
oaire.citationStartPage83por
oaire.citationEndPage83por
oaire.citationIssueSuppl. 4-
oaire.citationConferencePlaceLisbon, Portugalpor
oaire.citationTitle7th Trends in Medical Mycologypor
oaire.citationVolume58-
dc.date.updated2015-10-21T18:36:42Z-
dc.subject.wosScience & Technologypor
sdum.journalMycosespor
Aparece nas coleções:CEB - Resumos em Livros de Atas / Abstracts in Proceedings

Ficheiros deste registo:
Ficheiro Descrição TamanhoFormato 
document_23442_1.pdf138,89 kBAdobe PDFVer/Abrir

Partilhe no FacebookPartilhe no TwitterPartilhe no DeliciousPartilhe no LinkedInPartilhe no DiggAdicionar ao Google BookmarksPartilhe no MySpacePartilhe no Orkut
Exporte no formato BibTex mendeley Exporte no formato Endnote Adicione ao seu ORCID